American National Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Sell
15,875
-139
-0.9% -$142K 1.63% 16
2026
Q1
$14.7M Buy
16,014
+103
+0.6% +$104K 1.41% 21
2025
Q4
$17.1M Sell
15,911
-264
-2% -$252K 1.62% 16
2025
Q3
$12.3M Sell
16,175
-1,340
-8% -$997K 1.22% 26
2025
Q2
$13.7M Buy
17,515
+3,368
+24% +$2.62M 1.4% 22
2025
Q1
$11.7M Buy
14,147
+6,219
+78% +$5.17M 1.3% 26
2024
Q4
$6.12M Buy
7,928
+1,347
+20% +$1.12M 0.68% 45
2024
Q3
$5.83M Sell
6,581
-14
-0.2% -$12.6K 0.69% 44
2024
Q2
$5.97M Buy
6,595
+100
+2% +$80K 0.74% 41
2024
Q1
$5.05M Sell
6,495
-224
-3% -$159K 0.67% 45
2023
Q4
$3.92M Sell
6,719
-1,959
-23% -$1.14M 0.62% 48
2023
Q3
$4.66M Sell
8,678
-578
-6% -$298K 0.79% 43
2023
Q2
$4.34M Sell
9,256
-901
-9% -$378K 0.73% 45
2023
Q1
$3.49M Buy
10,157
+633
+7% +$213K 0.64% 49
2022
Q4
$3.48M Buy
9,524
+374
+4% +$133K 0.71% 46
2022
Q3
$2.96M Sell
9,150
-54
-0.6% -$17.1K 0.71% 43
2022
Q2
$2.98M Sell
9,204
-19
-0.2% -$5.7K 0.71% 42
2022
Q1
$2.64M Sell
9,223
-757
-8% -$195K 0.52% 48
2021
Q4
$2.76M Buy
9,980
+548
+6% +$139K 0.54% 46
2021
Q3
$2.18M Buy
9,432
+11
+0.1% +$2.71K 0.48% 46
2021
Q2
$2.16M Buy
9,421
+1,343
+17% +$270K 0.46% 46
2021
Q1
$1.51M Buy
8,078
+868
+12% +$170K 0.36% 47
2020
Q4
$1.22M Hold
7,210
0.31% 50
2020
Q3
$1.07M Buy
7,210
+1,030
+17% +$159K 0.3% 46
2020
Q2
$1.01M Sell
6,180
-465
-7% -$71.4K 0.33% 46
2020
Q1
$922K Buy
6,645
+5,535
+499% +$761K 0.36% 46
2019
Q4
$146K Buy
1,110
+420
+61% +$48.7K 0.04% 99
2019
Q3
$77K Hold
690
0.02% 110
2019
Q2
$76K Hold
690
0.02% 111
2019
Q1
$90K Sell
690
-4,536
-87% -$552K 0.03% 113
2018
Q4
$605K Hold
5,226
0.22% 62
2018
Q3
$561K Buy
5,226
+245
+5% +$24.5K 0.16% 74
2018
Q2
$425K Sell
4,981
-57
-1% -$4.68K 0.12% 98
2018
Q1
$390K Buy
5,038
+588
+13% +$47.3K 0.11% 96
2017
Q4
$376K Buy
4,450
+2,362
+113% +$201K 0.11% 101
2017
Q3
$179K Hold
2,088
0.05% 109
2017
Q2
$172K Buy
2,088
+104
+5% +$8.48K 0.06% 110
2017
Q1
$167K Sell
1,984
-1,771
-47% -$142K 0.05% 108
2016
Q4
$276K Buy
3,755
+1,225
+48% +$91.2K 0.09% 87
2016
Q3
$203K Buy
2,530
+350
+16% +$28K 0.07% 89
2016
Q2
$172K Sell
2,180
-567
-21% -$42.7K 0.06% 95
2016
Q1
$198K Hold
2,747
0.07% 83
2015
Q4
$231K Hold
2,747
0.09% 80
2015
Q3
$230K Hold
2,747
0.1% 84
2015
Q2
$229K Hold
2,747
0.09% 79
2015
Q1
$199K Buy
2,747
+340
+14% +$24.2K 0.08% 82
2014
Q4
$166K Hold
2,407
0.06% 93
2014
Q3
$156K Buy
+2,407
New +$152K 0.06% 87

Other funds holding LLY

American National Bank & Trust's LLY Position: Q2 2026 in Review

American National Bank & Trust reduced its Eli Lilly (LLY) stake by 0.87% in Q2 2026, selling an estimated $142K and leaving 15,875 shares worth $19M. The position accounts for 1.63% of the portfolio, ranked #16.

American National Bank & Trust first reported a position in LLY in Q3 2014 and has held it in 48 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • American National Bank & Trust held 15,875 shares of Eli Lilly worth $19M as of Q2 2026.
  • American National Bank & Trust sold 139 Eli Lilly shares in Q2 2026, an estimated $142K.
  • Eli Lilly made up 1.63% of American National Bank & Trust's portfolio in Q2 2026, its #16 holding.
  • American National Bank & Trust first reported a position in Eli Lilly in Q3 2014 and has held it in 48 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.